$0.00
(+0.00%
) Quote detailsUSD
( +0.00%
At Close (As of Jan 1, 1970)
$80.22M
Market Cap
-
P/E Ratio
-2.9
EPS
$16.94
52 Week High
$1.80
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
CervoMed Inc. is a Boston-based clinical-stage biotechnology company focused on developing groundbreaking therapeutics for neurodegenerative diseases, notably Alzheimer's and Parkinson's. Leveraging cutting-edge research methodologies and a strong drug pipeline, the company addresses significant unmet medical needs within this complex therapeutic landscape. With its dedication to innovation and strategic drug development, CervoMed holds potential as a transformative force in treatment paradigms, presenting compelling opportunities for both patient outcomes and investor value.
LPTX
WOK
VSME
PETS
NVDA
VHAI
F
KIND
ORCL
ADAP
IRBT
PLUG
K
HBAN
ASST
WULF
TSLA
IVP
MTSR
INTC
WRBY
MSTR
HOOD
NFLX
RGTI
RR
SOFI
AAL
AMC
PLTR
PLTD
DNN
BITF
CCL
MARA
FCX
ACIU
CARR
IREN
RKLB
CIFR
FUBO
NIO
WBD
RIOT
GM
CAN
SHOT
BAC
ZAPP
QBTS
AVGO
BTBT
CNQ
NOK
NWL
PFE
RIG
AMD
CFLT
HPQ
HAL
SPR
SMR
ALIT
CDE
LPTX
WOK
VSME
PETS
NVDA
VHAI
F
KIND
ORCL
ADAP
IRBT
PLUG
K
HBAN
ASST
WULF
TSLA
IVP
MTSR
INTC
WRBY
MSTR
HOOD
NFLX
RGTI
RR
SOFI
AAL
AMC
PLTR
PLTD
DNN
BITF
CCL
MARA
FCX
ACIU
CARR
IREN
RKLB
CIFR
FUBO
NIO
WBD
RIOT
GM
CAN
SHOT
BAC
ZAPP
QBTS
AVGO
BTBT
CNQ
NOK
NWL
PFE
RIG
AMD
CFLT
HPQ
HAL
SPR
SMR
ALIT
CDE